ADA Scientific Sessions 2026 Abstract·6 JunIBI3040, a Novel Amylin Analog, Induces Superior Weight Loss in Preclinical ModelsExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·6 JunIBI3042: A Novel Oral Once-Weekly Small-Molecule GLP-1 Receptor Agonist for Type 2 Diabetes and ObesityExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunIBI3032: An Orally Bioavailable Nonpeptidic GLP-1 Receptor Agonist Advancing through Phase 1 Clinical TrialsExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel Antibody–Peptide Conjugate Targeting PCSK9,GLP-1R,GCGR,GIPR Improves Cardiovascular Risk Markers in Preclinical StudyExperiments in animalsInterventionsPaper